Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Analytical Diagnostic Solutions Inc
Profile last edited on: 9/1/23      CAGE: 6XC51      UEI: QNDYVJB4AQG3

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
2011
First Award
2017
Latest Award
2022
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

8 Abington Road
Mount Laurel, NJ 08054
   (856) 343-5098
   invitrodiagnosticsolutions@gmail.com
   N/A
Location: Single
Congr. District: 03
County: Burlington

Public Profile

A puzzle: Originally entered into the SBIR systems as Analytical Diagnostic Solutions - and recorded as successfully in receipt of other awards to include a creditable Phase II track record -- bringing the firm into a multi-million operation - along the way the firm appears to have changed its name to "In Vitro Diagnostic Solutions" - still in New Jersey but relocated and with an expanded staff.

Extent of SBIR involvement

User Avatar
Phase I Awards
4
Phase II Awards
2
Conversion Rate
50.00%
Phase I Dollars
$865,620
Phase II Dollars
$5,305,070
Total Awarded
$6,170,690

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
5-9

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2023 1 NIH $300,000
Project Title: ADA2 Diagnostic Platform: Point-of-care test for determination of patient enzyme levels for diagnosis of the rare disease Deaminase2 Deficiency (DADA2)
2023 2 NIH $4,531,714
Project Title: A user-friendly point-of-care device for G6PDH determination
2021 2 NIH $2,171,657
Project Title: A Point-Of-Care Device for Phenylalanine Determination
2018 1 NIH $224,700
Project Title: A Point-Of-Care Device for the Determination of the Bilirubin, the Bilinow
2018 1 NSF $225,000
Project Title: A user-friendly point-of-care device for simultaneous G6PDH and hemoglobin determination

Key People / Management

  Robert Harper -- Founder, President & CEO

Company News

There are no news available.